Xilio rises after surprise quarterly profit

Xilio Therapeutics

23/03/2026 12:45

** Shares of drug developer Xilio Therapeutics XLO.O rise 3.18% to $8.11 premarket

** Co posts Q4 profit of 81 cents per share, while analysts were expecting loss of $1.68 per share - data compiled by LSEG

** Posts Q4 revenue of $13.7 million vs estimate of $7.9 million

** Says quarterly revenue rose on higher collaboration and license revenue, driven by its AbbVie collaboration and Gilead license agreement

** XLO shares were down over 32% in 2025

 (Reporting by Kunal Das in Bengaluru)

 ((Kunal.Das2@thomsonreuters.com;))